COPD Research

Published Online: Thursday, January 16, 2014
Follow Pharmacy_Times:
Martin R. Stämpfli, PhD, professor in the department of medicine at McMaster University, explains the development of COPD in his lecture at the seminar “COPD—Bridging the Gap between Science and Clinical Care.”

Related Articles
Galleon Pharmaceuticals Corp's GAL-021 reverses and prevents respiratory depression associated with opioid use without affecting analgesia.
A recent article suggests that comparing 2 or more observations of a patient’s COPD symptoms over time can help clinicians learn why patients lose control of the disease.
Latest Issues
$auto_registration$